Journal for ImmunoTherapy of Cancer

Published by: Biomed Central Ltd  

People

  1. Klebanoff
    Klebanoff
  2. Balachandran
    Balachandran
  3. Hakimi
    Hakimi
  4. Rudin
    Rudin
  5. Chandran
    Chandran
  6. Chan
    Chan
  7. Guasp Baratech
    Guasp Baratech
  8. Iacobuzio-Donahue
    Iacobuzio-Donahue
  9. Kuo
    Kuo
  10. Odgerel
    Odgerel

Groups

  1. Human Oncology and Pathogenesis Program (17)
  2. GSK Faculty (16)
  3. Department of Medicine (14)
  4. Hematologic Malignancies, Division of (11)
  5. Solid Tumor Oncology Division (11)
  6. Sloan Kettering Institute Postdocs (10)
  7. Surgery (9)
  8. Epidemiology and Biostatistics (7)
  9. Graduate Medical Education (7)
  10. Tow Center for Developmental Oncology (TCDO) (7)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (7)
Groups
  1. Human Oncology and Pathogenesis Program (17)
  2. GSK Faculty (16)
  3. Department of Medicine (14)
  4. Hematologic Malignancies, Division of (11)
  5. Solid Tumor Oncology Division (11)
  6. Sloan Kettering Institute Postdocs (10)

More Groups

People
  1. Christopher Klebanoff (4)
  2. Vinod Balachandran (4)
  3. Abraham Hakimi (3)
  4. Charles Rudin (3)
  5. Jedd Wolchok (3)
  6. Taha Merghoub (3)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (4)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (3)

More Years

Publishers
  1. Biomed Central Ltd (17)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Developing a membrane-proximal CD33-targeting CAR T cell
    Journal Article

    Freeman, R.; Shahid, S.; Khan, A. G.; Mathew, S. C.; Souness, S.; Burns, E. R.; Um, J. S.; Tanaka, K.; Cai, W.; Yoo, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma
    Journal Article

    Chakiryan, N. H.; Kim, Y.; Berglund, A.; Chang, A.; Kimmel, G. J.; Hajiran, A.; Nguyen, J.; Moran-Segura, C.; Saeed-Vafa, D.; Katende, E. N.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Gut dysbiosis suppresses anti-tumor ILC2S in pancreatic cancer
    Meeting Abstract

    Zebboudj, A.; Amisaki, M.; Guasp, P.; Rojas, L.; Sethna, Z.; Theresa, W.; Chandra, A.; Yu, R.; Odgerel, Z.; Soares, K.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Small cell lung cancer molecular subtypes and vulnerability to immune checkpoint blockade
    Meeting Abstract

    Nabet, B.; Hamidi, H.; Banchereau, R.; Morris, S.; Adler, L.; Srivastava, M.; Patil, N.; Gay, C.; Minna, J.; Heymach, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Meeting Abstract

    Etxeberria, I.; Banks, L.; Chandran, S.; Correa, A.; Novak, B.; Fleischman, J.; Drilon, A.; Wolchok, J.; Merghoub, T.; Klebanoff, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
    Journal Article

    Rosenbaum, E.; Antonescu, C. R.; Smith, S.; Bradic, M.; Kashani, D.; Richards, A. L.; Donoghue, M.; Kelly, C. M.; Nacev, B.; Chan, J. E.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Toxicity of an Fc engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable anti-tumor immunity in patients
    Meeting Abstract

    Knorr, D.; Ravetch, J.; D'Andrea, G.; Vahdat, L.; Klebanoff, C.; Robson, M.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save

    • Journal for ImmunoTherapy of Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer BMJ Publishing Group Ltd.
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer BMJ Publishing Group Ltd.
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Emp Oyer(s)) 2025
    Journal for ImmunoTherapy of Cancer 20511426 Unknown
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s)) 2025
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 The Author(s)
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 BMJ Group
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer 2051-1426 Bmc
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s)) 2024
    Journal for ImmunoTherapy of Cancer 2017 Nov 8-12 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Bmj
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s))
    Unknown (2051-1426) 2051-1426 Biomed Central Ltd